Gilbert & Cook’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-10,355
Closed -$662K 216
2023
Q2
$662K Buy
10,355
+657
+7% +$44.1K 0.11% 81
2023
Q1
$672K Buy
9,698
+104
+1% +$7.33K 0.12% 72
2022
Q4
$690K Buy
9,594
+132
+1% +$9.95K 0.13% 68
2022
Q3
$733K Buy
9,462
+160
+2% +$11.6K 0.16% 64
2022
Q2
$716K Sell
9,302
-424
-4% -$32.3K 0.13% 64
2022
Q1
$710K Buy
9,726
+972
+11% +$65.3K 0.11% 71
2021
Q4
$546K Buy
8,754
+991
+13% +$58.1K 0.09% 104
2021
Q3
$459K Buy
7,763
+2,935
+61% +$193K 0.08% 116
2021
Q2
$323K Buy
4,828
+94
+2% +$6.13K 0.06% 151
2021
Q1
$299K Buy
4,734
+871
+23% +$54.2K 0.06% 146
2020
Q4
$241K Buy
3,863
+537
+16% +$33K 0.05% 160
2020
Q3
$201K Buy
+3,326
New +$200K 0.05% 151

Other funds holding BMY

Gilbert & Cook's BMY Position: Q3 2023 in Review

Gilbert & Cook sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 10,355 shares — an estimated $662K sold.

Gilbert & Cook first reported a position in BMY in Q3 2020 and held it in 12 quarters. The position peaked at $733K in Q3 2022. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • Gilbert & Cook reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • Gilbert & Cook sold 10,355 Bristol-Myers Squibb shares in Q3 2023, an estimated $662K.
  • Gilbert & Cook first reported a position in Bristol-Myers Squibb in Q3 2020 and held it in 12 quarters.
  • Gilbert & Cook's Bristol-Myers Squibb position peaked at $733K in Q3 2022.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Gilbert & Cook's 13F filing for Q3 2023, filed 2 Nov 2023.